![](https://investorshub.advfn.com/uicon/381315.png?cb=1663793788)
Wednesday, September 14, 2022 3:07:09 PM
Recent BIAF News
- IBM Closes China Research Division, Uber Fined $324M, Starliner to Return Without Astronauts • IH Market News • 08/26/2024 12:58:21 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 08/23/2024 09:17:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/23/2024 09:15:20 PM
- bioAffinity Technologies CFO to Depart for New Opportunity; J. Michael Edwards to Return as Interim CFO • Business Wire • 08/23/2024 09:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/14/2024 08:19:01 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 08/14/2024 08:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 01:37:24 PM
- bioAffinity Technologies Reports $2.4 Million Revenue for Q2 Driven by Growing CyPath® Lung Sales • Business Wire • 08/14/2024 01:25:00 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/12/2024 08:00:22 PM
- WallachBeth Capital Announces Closing of bioAffinity Technologies Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million • PR Newswire (US) • 08/05/2024 06:00:00 PM
- bioAffinity Technologies Announces Closing of Registered Direct Offering, Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million • Business Wire • 08/05/2024 05:17:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/05/2024 01:03:01 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/05/2024 01:00:28 PM
- WallachBeth Capital Announces bioAffinity Technologies Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million • PR Newswire (US) • 08/02/2024 02:00:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 08/02/2024 01:30:13 PM
- bioAffinity Technologies Announces Pricing of Registered Direct Offering and Concurrent Private Placement and Warrant Inducement for Aggregate Gross Proceeds of $1.75 Million • Business Wire • 08/02/2024 01:25:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/09/2024 08:30:12 PM
- bioAffinity Technologies Reports 217% Sales Growth in Second Quarter 2024 for CyPath® Lung • Business Wire • 07/09/2024 12:00:00 PM
- bioAffinity Technologies Reports Accelerating Growth of Physician Practices Ordering CyPath® Lung Tests • Business Wire • 06/12/2024 12:00:00 PM
- bioAffinity Technologies Reports Record Q1 Revenue Driven by Accelerating Growth of CyPath® Lung Sales and Increased Laboratory Volumes • Business Wire • 05/15/2024 01:15:00 PM
- bioAffinity Technologies News Update • Business Wire • 05/02/2024 12:00:00 PM
- bioAffinity Technologies Advances New Product Development Initiatives to Accelerate Next Phase of Growth • Business Wire • 04/24/2024 12:00:00 PM
- bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening • Business Wire • 04/09/2024 12:00:00 PM
- bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results • Business Wire • 04/01/2024 01:49:00 PM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM